Metformin Aaa-Pharma

Metformin Hydrochloride, the active ingredient in Metformin Aaa-Pharma, is a Biguanide presented as a tablet for oral use. It treats type 2 diabetes mellitus in adult patients by improving blood glucose control. It works by decreasing hepatic glucose production and increasing peripheral insulin sensitivity, helping to lower fasting and post‑prandial glucose levels.

GNH USA supplies Metformin Aaa-Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metformin is an oral antidiabetic medication used to improve glycaemic control in the type 2 diabetes pathway.

- Type 2 diabetes mellitus: lowers fasting and post‑prandial blood glucose levels. - Non‑diabetic hyperglycemia (prediabetes): delays progression to overt diabetes. - Combination therapy with insulin: enhances overall glucose control when added to insulin regimens.

Metformin may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Gastrointestinal upset: nausea, abdominal discomfort, and loss of appetite. - Diarrhea: frequent loose stools, especially during treatment initiation. - Metallic taste: transient alteration of taste perception. - Flatulence: increased intestinal gas.

Serious or Rare Side Effects: - Lactic acidosis: rare but potentially fatal metabolic disturbance. - Severe skin reactions: such as Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Hepatic dysfunction: marked elevation of liver enzymes. - Vitamin B12 deficiency: long‑term use may reduce absorption.

When prescribing Metformin, several safety considerations should be observed.

- Renal function assessment: evaluate eGFR before initiation and periodically. - Hepatic function monitoring: avoid use in patients with significant liver disease. - Cardiovascular status: use cautiously in patients with unstable or acute heart failure. - Concomitant alcohol intake: limit alcohol to reduce risk of lactic acidosis. - Pregnancy and lactation: assess risk‑benefit; use only if clearly needed. - Store at room temperature: keep in the original container, protect from moisture and heat.

Metformin interacts with several medicines that can alter its plasma concentration or increase the risk of adverse events.

Major Interactions (Avoid): - Iodinated contrast agents: may cause acute renal failure, increasing lactic acidosis risk. - Cimetidine: can raise metformin plasma levels, enhancing toxicity. - Alcohol: excessive intake heightens lactic acidosis potential.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: monitor renal function and potassium levels. - Beta‑blockers: may mask hypoglycaemia symptoms. - Thiazide diuretics: can attenuate glucose‑lowering effect. - NSAIDs: may impair renal clearance, requiring dose adjustment.